Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial

Recruiting N/A Interventional Study
Cardiogenic Shock Heart Failure Ambulatory Hemodynamic Monitoring
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
40 (estimated)
Sponsor
Inova Health Care Services · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Pilot Prospective Randomized Unblinded Pragmatic Trial of Pulmonary Artery Hemodynamic Monitoring Following Hospitalization for Cardiogenic Shock

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Subject or legal representative has signed Informed Consent Form (ICF) and the patient has the capacity to participate in the study and complete the study questionnaires, in the estimation of the study investigator. 2. Age ≥ 18 years 3. NYHA Class III with dyspnea upon mild p…
Contacts

Shashank Sinha, MD MSc

7037764001

shashank.sinha@inova.org

CONTACT

Bhruga Shah, MPH

17037762828

Bhruga.shah@inova.org

CONTACT